세계의 ACL 그래프트 시장 : 시장 규모 - ACL 수술 유형별, 연령별, 성별, 상해별, 최종 사용자별, 지역별 분석 및 예측(2022-2032년)

The Global ACL Graft Market, currently valued at approximately USD 0.11 billion in 2023, is poised for substantial growth at a healthy CAGR of 7.20% during the forecast period 2024-2032. The anterior cruciate ligament (ACL) graft market is intricately linked with advancements in surgical procedures and materials. With sports-related injuries becoming increasingly common, coupled with a rising focus on minimally invasive procedures, the market is undergoing a transformative phase. This field combines cutting-edge techniques in graft material engineering and surgical precision to meet the growing demand for effective ACL reconstruction and revision solutions.

The prevalence of sports injuries, particularly among young athletes, serves as a primary catalyst for market growth. In addition to sports injuries, rising cases of non-sports-related ligament tears are driving the need for specialized treatment options. Modern ACL graft solutions focus on reducing recovery times and enhancing patient outcomes, making them highly appealing to both patients and healthcare providers. Concurrently, advancements in synthetic grafts and tissue engineering technologies are paving the way for innovative solutions, providing alternatives to traditional autografts and allografts.

Despite the promising growth trajectory, the ACL Graft Market faces significant hurdles. High costs associated with advanced surgical procedures and graft materials may deter widespread adoption in low-income regions. Additionally, challenges such as post-operative complications and graft failure rates necessitate rigorous clinical evaluation and quality assurance. However, sustained investments in R&D and supportive healthcare infrastructure are mitigating these barriers, gradually expanding the accessibility and affordability of ACL graft procedures globally.

Regionally, North America commands the largest share of the ACL Graft Market, attributed to its robust healthcare infrastructure, high incidence of sports injuries, and an early adoption of advanced surgical techniques. The presence of key market players in the U.S. further fuels innovation and accessibility in the region. Meanwhile, the Asia Pacific region is expected to exhibit the fastest growth rate, driven by a burgeoning population, increasing sports participation, and improving healthcare infrastructure in countries such as India, China, and Japan.

Major market players included in this report are:

• Zimmer Biomet Holdings, Inc.
• Smith & Nephew plc
• Arthrex, Inc.
• ConMed Corporation
• Stryker Corporation
• DJO Global, Inc.
• DePuy Synthes (Johnson & Johnson)
• Medtronic plc
• Ossur hf
• Parcus Medical, LLC
• LifeNet Health, Inc.
• Wright Medical Group N.V.
• Exactech, Inc.
• RTI Surgical Holdings, Inc.
• Integra LifeSciences Corporation

The detailed segments and sub-segment of the market are explained below:

By Type of ACL Surgery

• Reconstruction
• Revision

By Age

• Above 19 years
• Below 19 years

By Gender

• Male
• Female

By Injury

• Sports Injuries
• Non-Sports Injuries

By End User

• Hospitals
• Orthopedic Clinics
• Ambulatory Surgical Centers
• Others

By Region:

• North America
• U.S.
• Canada
• Europe
• UK
• Germany
• France
• Spain
• Italy
• Rest of Europe
• Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• Rest of Asia Pacific
• Latin America
• Brazil
• Mexico
• Middle East & Africa
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Years considered for the study are as follows:

• Historical year - 2022
• Base year - 2023
• Forecast period - 2024 to 2032

Key Takeaways:

• Comprehensive market estimates and forecasts spanning 10 years.
• Detailed segmental and regional analysis with actionable insights.
• Identification of key growth drivers, challenges, and market opportunities.
• Competitive analysis and strategic recommendations for market players.
• In-depth coverage of leading players' strategies and innovations.

Table of Contents

Chapter 1. Global ACL Graft Market Executive Summary

• 1.1. Global ACL Graft Market Size & Forecast (2022-2032)
• 1.2. Regional Summary
• 1.3. Segmental Summary
  • 1.3.1. By Type of ACL Surgery
  • 1.3.2. By Age
  • 1.3.3. By Gender
  • 1.3.4. By Injury
  • 1.3.5. By End User
• 1.4. Key Trends
• 1.5. Recession Impact
• 1.6. Analyst Recommendation & Conclusion

Chapter 2. Global ACL Graft Market Definition and Research Assumptions

• 2.1. Research Objective
• 2.2. Market Definition
• 2.3. Research Assumptions
  • 2.3.1. Inclusion & Exclusion
  • 2.3.2. Limitations
  • 2.3.3. Supply Side Analysis
    • 2.3.3.1. Availability
    • 2.3.3.2. Infrastructure
    • 2.3.3.3. Regulatory Environment
    • 2.3.3.4. Market Competition
    • 2.3.3.5. Economic Viability (Consumer's Perspective)
  • 2.3.4. Demand Side Analysis
    • 2.3.4.1. Regulatory Frameworks
    • 2.3.4.2. Technological Advancements
    • 2.3.4.3. Environmental Considerations
    • 2.3.4.4. Consumer Awareness & Acceptance
• 2.4. Estimation Methodology
• 2.5. Years Considered for the Study
• 2.6. Currency Conversion Rates

Chapter 3. Global ACL Graft Market Dynamics

• 3.1. Market Drivers
  • 3.1.1. Increasing Prevalence of Sports Injuries Among Young Athletes
  • 3.1.2. Rising Incidence of Non-Sports-Related Ligament Tears
  • 3.1.3. Advancements in ACL Graft Solutions Improving Patient Outcomes
• 3.2. Market Challenges
  • 3.2.1. High Costs of Advanced Surgical Procedures and Graft Materials
  • 3.2.2. Post-Operative Complications and Graft Failure Rates
• 3.3. Market Opportunities
  • 3.3.1. Increased Investments in R&D and Supportive Healthcare Infrastructure
  • 3.3.2. Growing Demand in Emerging Markets, Especially Asia Pacific Region
  • 3.3.3. Development of Innovative Synthetic Graft Materials and Minimally Invasive Techniques

Chapter 4. Global ACL Graft Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model
  • 4.1.7. Porter's 5 Force Impact Analysis
• 4.2. PESTEL Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
  • 4.2.5. Environmental
  • 4.2.6. Legal
• 4.3. Top Investment Opportunity
• 4.4. Top Winning Strategies
• 4.5. Disruptive Trends
• 4.6. Industry Expert Perspective
• 4.7. Analyst Recommendation & Conclusion

Chapter 5. Global ACL Graft Market Size & Forecasts by Type of ACL Surgery 2022-2032

• 5.1. Segment Dashboard
• 5.2. Global ACL Graft Market: Type of ACL Surgery Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 5.2.1. Reconstruction
  • 5.2.2. Revision

Chapter 6. Global ACL Graft Market Size & Forecasts by Age 2022-2032

• 6.1. Segment Dashboard
• 6.2. Global ACL Graft Market: Age Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 6.2.1. Above 19 Years
  • 6.2.2. Below 19 Years

Chapter 7. Global ACL Graft Market Size & Forecasts by Gender 2022-2032

• 7.1. Segment Dashboard
• 7.2. Global ACL Graft Market: Gender Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 7.2.1. Male
  • 7.2.2. Female

Chapter 8. Global ACL Graft Market Size & Forecasts by Injury 2022-2032

• 8.1. Segment Dashboard
• 8.2. Global ACL Graft Market: Injury Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 8.2.1. Sports Injuries
  • 8.2.2. Non-Sports Injuries

Chapter 9. Global ACL Graft Market Size & Forecasts by End User 2022-2032

• 9.1. Segment Dashboard
• 9.2. Global ACL Graft Market: End User Revenue Trend Analysis, 2022 & 2032 (USD Million/Billion)
  • 9.2.1. Hospitals
  • 9.2.2. Orthopedic Clinics
  • 9.2.3. Ambulatory Surgical Centers
  • 9.2.4. Others

Chapter 10. Global ACL Graft Market Size & Forecasts by Region 2022-2032

• 10.1. North America ACL Graft Market
  • 10.1.1. U.S. ACL Graft Market
    • 10.1.1.1. Type of ACL Surgery Breakdown Size & Forecasts, 2022-2032
    • 10.1.1.2. Age Breakdown Size & Forecasts, 2022-2032
    • 10.1.1.3. Gender Breakdown Size & Forecasts, 2022-2032
    • 10.1.1.4. Injury Breakdown Size & Forecasts, 2022-2032
    • 10.1.1.5. End User Breakdown Size & Forecasts, 2022-2032
  • 10.1.2. Canada ACL Graft Market
    • 10.1.2.1. Type of ACL Surgery Breakdown Size & Forecasts, 2022-2032
    • 10.1.2.2. Age Breakdown Size & Forecasts, 2022-2032
    • 10.1.2.3. Gender Breakdown Size & Forecasts, 2022-2032
    • 10.1.2.4. Injury Breakdown Size & Forecasts, 2022-2032
    • 10.1.2.5. End User Breakdown Size & Forecasts, 2022-2032
• 10.2. Europe ACL Graft Market
  • 10.2.1. UK ACL Graft Market
    • 10.2.1.1. Type of ACL Surgery Breakdown Size & Forecasts, 2022-2032
    • 10.2.1.2. Age Breakdown Size & Forecasts, 2022-2032
    • 10.2.1.3. Gender Breakdown Size & Forecasts, 2022-2032
    • 10.2.1.4. Injury Breakdown Size & Forecasts, 2022-2032
    • 10.2.1.5. End User Breakdown Size & Forecasts, 2022-2032
  • 10.2.2. Germany ACL Graft Market
  • 10.2.3. France ACL Graft Market
  • 10.2.4. Spain ACL Graft Market
  • 10.2.5. Italy ACL Graft Market
  • 10.2.6. Rest of Europe ACL Graft Market
• 10.3. Asia-Pacific ACL Graft Market
  • 10.3.1. China ACL Graft Market
  • 10.3.2. India ACL Graft Market
  • 10.3.3. Japan ACL Graft Market
  • 10.3.4. Australia ACL Graft Market
  • 10.3.5. South Korea ACL Graft Market
  • 10.3.6. Rest of Asia Pacific ACL Graft Market
• 10.4. Latin America ACL Graft Market
  • 10.4.1. Brazil ACL Graft Market
  • 10.4.2. Mexico ACL Graft Market
  • 10.4.3. Rest of Latin America ACL Graft Market
• 10.5. Middle East & Africa ACL Graft Market
  • 10.5.1. Saudi Arabia ACL Graft Market
  • 10.5.2. South Africa ACL Graft Market
  • 10.5.3. Rest of Middle East & Africa ACL Graft Market

Chapter 11. Competitive Intelligence

• 11.1. Key Company SWOT Analysis
  • 11.1.1. Zimmer Biomet Holdings, Inc.
  • 11.1.2. Smith & Nephew plc
  • 11.1.3. Arthrex, Inc.
• 11.2. Top Market Strategies
• 11.3. Company Profiles
  • 11.3.1. Zimmer Biomet Holdings, Inc.
    • 11.3.1.1. Key Information
    • 11.3.1.2. Overview
    • 11.3.1.3. Financial (Subject to Data Availability)
    • 11.3.1.4. Product Summary
    • 11.3.1.5. Market Strategies
  • 11.3.2. Smith & Nephew plc
  • 11.3.3. Arthrex, Inc.
  • 11.3.4. ConMed Corporation
  • 11.3.5. Stryker Corporation
  • 11.3.6. DJO Global, Inc.
  • 11.3.7. DePuy Synthes (Johnson & Johnson)
  • 11.3.8. Medtronic plc
  • 11.3.9. Ossur hf
  • 11.3.10. Parcus Medical, LLC
  • 11.3.11. LifeNet Health, Inc.
  • 11.3.12. Wright Medical Group N.V.
  • 11.3.13. Exactech, Inc.
  • 11.3.14. RTI Surgical Holdings, Inc.
  • 11.3.15. Integra LifeSciences Corporation

Chapter 12. Research Process

• 12.1. Research Process
  • 12.1.1. Data Mining
  • 12.1.2. Analysis
  • 12.1.3. Market Estimation
  • 12.1.4. Validation
  • 12.1.5. Publishing
• 12.2. Research Attributes